Clinical utility of genetic and genomic services: context matters.

about

Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity.EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.

P2860

Q41526681-C2BF2294-FE02-4717-B97B-BF8659A6D924 Q46486965-2DD1153A-2577-46D0-BDB2-BA1C4B9B77D4

P2860

Clinical utility of genetic and genomic services: context matters.

Item

http://www.wikidata.org/entity/Q42734175

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical utility of genetic and genomic services: context matters.

@en

Clinical utility of genetic and genomic services: context matters.

@nl

type

Item

label

Clinical utility of genetic and genomic services: context matters.

@en

Clinical utility of genetic and genomic services: context matters.

@nl

prefLabel

Clinical utility of genetic and genomic services: context matters.

@en

Clinical utility of genetic and genomic services: context matters.

@nl

P1476

Clinical utility of genetic and genomic services: context matters.

@en

P2093

M Scott Bowen

http://www.w3.org/2001/XMLSchema#string

W David Dotson

http://www.w3.org/2001/XMLSchema#string

P2860

Cascade screening: whose information is it anyway?

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Achieving the "triple aim" for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework.

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Outcomes of interest in evidence-based evaluations of genetic tests.

Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children.

How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom

P2888

gim.2015.153

P304

672-674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2015.153

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Muin J. Khoury

Katherine Kolor

P577

2015-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286512233

http://www.w3.org/2001/XMLSchema#string

P6179

1009972976

http://www.w3.org/2001/XMLSchema#string

P698

26656648

http://www.w3.org/2001/XMLSchema#string

P932

4902786

http://www.w3.org/2001/XMLSchema#string

Clinical utility of genetic and genomic services: context matters.

about

P2860

P2860

Clinical utility of genetic and genomic services: context matters.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P6179

P698

P932